Japanese Pharmaceuticals and Medical Devices Agency (PMDA) has approved LimFlow’s Clinical Trial Notification (CTN) for the Japanese cohort of the … continue reading “Japan Approves LimFlow Study”
News
‘UK Healthcare Pavilion’ Partnership Gateway to Middle East
The UK Healthcare Pavilion – the first virtual platform showcasing the very best of UK healthcare and Life Sciences – has … continue reading “‘UK Healthcare Pavilion’ Partnership Gateway to Middle East”
SINUVA® Sinus Implant Reimbursement Picture Clears
ENT technology company Intersect ENT®, Inc., has announced that the U.S. Centers for Medicare and Medicaid Services (CMS) have published … continue reading “SINUVA® Sinus Implant Reimbursement Picture Clears”
CE Mark for Robotic Cancer Detection Probe
Now with CE mark approval, Lightpoint Medical’s SENSEI® becomes the first robotic gamma probe to be commercially available to European … continue reading “CE Mark for Robotic Cancer Detection Probe”
Althea Donates £100,000+ Covid-19 Support for NHS Charities
Leading medical equipment service provider Althea and its majority shareholder have announced the commitment of over £100,000 in charitable donations to … continue reading “Althea Donates £100,000+ Covid-19 Support for NHS Charities”
Scalp Cooling Gains Support for Prevention of Chemo-Induced Alopecia
The European Society for Medical Oncology (ESMO) has recommended scalp cooling for the prevention of chemotherapy-induced alopecia (CIA). Background Chemotherapy-induced … continue reading “Scalp Cooling Gains Support for Prevention of Chemo-Induced Alopecia”
FDA OKs ReCor Paradise™ Ultrasound Renal Denervation
ReCor Medical’s Paradise™ Ultrasound Renal Denervation System has received Breakthrough Device Designation from the U.S. FDA for the treatment of patients with uncontrolled hypertension who are inadequately responsive to anti-hypertensive medications.
Carpediem™ First Cardio-Renal Pediatric Dialysis Launch
Medtronic plc has announced the U.S. commercial launch of the Carpediem™ Cardio-Renal Pediatric Dialysis Emergency Machine, the first and only … continue reading “Carpediem™ First Cardio-Renal Pediatric Dialysis Launch”
Enrolment Complete in ISABELLA DEB Trial for Failing AV fistula
MedAlliance says it has completed patient enrolment in the ISABELLA Clinical Trial with SELUTION SLR™ 018 DEB (drug-eluting balloon) for the treatment … continue reading “Enrolment Complete in ISABELLA DEB Trial for Failing AV fistula”
App Boost for BioTech Businesses
Berlin-based Biotech networking company A-LabInsider has created an app that is a resource listing all academic life science labs in … continue reading “App Boost for BioTech Businesses”
GI Genius™ Colonoscopy AI UK First for The London Clinic
The London Clinic is the first hospital in the UK and one of the first in the world to employ the … continue reading “GI Genius™ Colonoscopy AI UK First for The London Clinic”
CytoSMART Launches First Fluorescence Live-Cell Imager
CytoSMART Technologies’ first fluorescence live-cell imager, Lux3 FL enables researchers to unravel cellular processes in real-time. Background CytoSMART Technologies is … continue reading “CytoSMART Launches First Fluorescence Live-Cell Imager”
FDA Says Yes to 130 Per Hour SARS-CoV-2 Test
in vitro diagnostics company, Ortho Clinical Diagnostics has announced that the U.S. FDA has accepted its Emergency Use Notification (EUN) … continue reading “FDA Says Yes to 130 Per Hour SARS-CoV-2 Test”
Commercial Payor Thumbs-Up for EpiFix Diabetic Foot Ulcer Treatment
The largest U.S. commercial payor will provide coverage for EpiFix in the treatment of diabetic foot ulcers Background Advanced wound … continue reading “Commercial Payor Thumbs-Up for EpiFix Diabetic Foot Ulcer Treatment”
EGM Builders Lets Ekso Bionics’ EVO™ Technology Take the Strain
“Exoskeleton” developer Ekso Bionics Holdings, Inc. tells us it has a first customer for its technology for its EVO™ units. … continue reading “EGM Builders Lets Ekso Bionics’ EVO™ Technology Take the Strain”
Strong Interim Results from Sequana Medical alfapump® DSR Study
Sequana Medical NV, an innovator in the management of fluid overload in liver disease, malignant ascites and heart failure, has … continue reading “Strong Interim Results from Sequana Medical alfapump® DSR Study”